• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄嘌呤氧化还原酶在动脉粥样硬化发病机制中的作用:不仅仅是氧化应激。

Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress.

作者信息

Battelli Maria Giulia, Polito Letizia, Bolognesi Andrea

机构信息

Alma Mater Studiorum University of Bologna, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, General Pathology Unit, Via S. Giacomo 14, 40126 Bologna, Italy.

出版信息

Atherosclerosis. 2014 Dec;237(2):562-7. doi: 10.1016/j.atherosclerosis.2014.10.006. Epub 2014 Oct 17.

DOI:10.1016/j.atherosclerosis.2014.10.006
PMID:25463089
Abstract

Endothelial xanthine oxidoreductase (XOR) together with NAD(P)H oxidase and nitric oxide (NO) synthase plays a physiologic role in inflammatory signalling, the regulation of NO production and vascular function. The oxidative stress generated by these enzymes may induce endothelial dysfunction, leading to atherosclerosis, cardiovascular diseases and metabolic syndrome. XOR activity creates both oxidant and anti-oxidant products that are implicated in the development of hypertension, smoking vascular injury, dyslipidemia and diabetes, which are the main risk factors of atherosclerosis. In particular, uric acid may have a protective as well as a detrimental role in vascular alterations, thus justifying the multi-directional effects of XOR inhibition. Moreover, XOR products are associated with cell differentiation, leading to adipogenesis and foam cell formation, as well as to the production of monocyte chemoattractant protein-1 from arterial smooth muscle cells, after proliferation and migration. The role of XOR in adipogenesis is also connected with insulin resistance and obesity, two main features of type 2 diabetes.

摘要

内皮黄嘌呤氧化还原酶(XOR)与NAD(P)H氧化酶和一氧化氮(NO)合酶一起在炎症信号传导、NO生成调节和血管功能中发挥生理作用。这些酶产生的氧化应激可能会导致内皮功能障碍,进而引发动脉粥样硬化、心血管疾病和代谢综合征。XOR活性产生的氧化产物和抗氧化产物都与高血压、吸烟导致的血管损伤、血脂异常和糖尿病的发生有关,而这些都是动脉粥样硬化的主要危险因素。特别是,尿酸在血管改变中可能具有保护作用和有害作用,因此说明了XOR抑制的多向效应。此外,XOR产物与细胞分化有关,导致脂肪生成和泡沫细胞形成,以及动脉平滑肌细胞在增殖和迁移后产生单核细胞趋化蛋白-1。XOR在脂肪生成中的作用还与胰岛素抵抗和肥胖有关,这是2型糖尿病的两个主要特征。

相似文献

1
Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress.黄嘌呤氧化还原酶在动脉粥样硬化发病机制中的作用:不仅仅是氧化应激。
Atherosclerosis. 2014 Dec;237(2):562-7. doi: 10.1016/j.atherosclerosis.2014.10.006. Epub 2014 Oct 17.
2
The role of xanthine oxidoreductase and uric acid in metabolic syndrome.黄嘌呤氧化还原酶和尿酸在代谢综合征中的作用。
Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2557-2565. doi: 10.1016/j.bbadis.2018.05.003. Epub 2018 May 5.
3
Mice heterozygous for the xanthine oxidoreductase gene facilitate lipid accumulation in adipocytes.杂合子黄嘌呤氧化还原酶基因的小鼠促进脂肪细胞中的脂质积累。
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):44-51. doi: 10.1161/ATVBAHA.113.302214. Epub 2013 Oct 24.
4
Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?慢性肾脏病:黄嘌呤氧化还原酶活性和产物的作用是什么?
Pharmacol Res. 2022 Oct;184:106407. doi: 10.1016/j.phrs.2022.106407. Epub 2022 Aug 20.
5
Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme.循环黄嘌呤氧化还原酶的病理生理学:一种多功能酶的新出现作用
Biochim Biophys Acta. 2014 Sep;1842(9):1502-17. doi: 10.1016/j.bbadis.2014.05.022. Epub 2014 May 29.
6
Xanthine Oxidoreductase in the Pathogenesis of Endothelial Dysfunction: An Update.黄嘌呤氧化酶在血管内皮功能障碍发病机制中的作用:最新研究进展。
Curr Hypertens Rev. 2024;20(1):10-22. doi: 10.2174/0115734021277772240124075120.
7
Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase.代谢综合征与癌症风险:黄嘌呤氧化还原酶的作用。
Redox Biol. 2019 Feb;21:101070. doi: 10.1016/j.redox.2018.101070. Epub 2018 Dec 7.
8
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.代谢性疾病中嘌呤代谢的新见解:黄嘌呤氧化还原酶活性的作用。
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E827-E834. doi: 10.1152/ajpendo.00378.2020. Epub 2020 Sep 7.
9
Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.高尿酸血症、内皮功能障碍与心血管疾病的关系:分子机制与临床意义。
J Cardiol. 2012 May;59(3):235-42. doi: 10.1016/j.jjcc.2012.01.013. Epub 2012 Mar 6.
10
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.黄嘌呤氧化还原酶与心血管疾病:分子机制及病理生理学意义
J Physiol. 2004 Mar 16;555(Pt 3):589-606. doi: 10.1113/jphysiol.2003.055913. Epub 2003 Dec 23.

引用本文的文献

1
Unveiling the Neurotoxic Effects of Ochratoxin A and Its Impact on Neuroinflammation.揭示赭曲霉毒素A的神经毒性作用及其对神经炎症的影响。
Toxins (Basel). 2025 May 23;17(6):264. doi: 10.3390/toxins17060264.
2
Association Between Serum Uric Acid and Atrial Fibrillation in Patients With Hypertension: A Systematic Review and Meta-Analysis.高血压患者血清尿酸与心房颤动之间的关联:一项系统评价与Meta分析
Rev Cardiovasc Med. 2025 May 27;26(5):28168. doi: 10.31083/RCM28168. eCollection 2025 May.
3
Liver-Derived, Circulating Xanthine Oxidoreductase Drives Vascular Impairment Associated with Inhalation of Ultrafine Particulates.
肝脏来源的循环黄嘌呤氧化还原酶驱动与吸入超细颗粒物相关的血管损伤。
bioRxiv. 2025 May 12:2025.05.07.652261. doi: 10.1101/2025.05.07.652261.
4
Evaluation of the Relationship Between Serum Uric Acid and Cardiovascular Disease: A Cross-Sectional Study in Bangladesh.血清尿酸与心血管疾病关系的评估:孟加拉国的一项横断面研究。
Endocrinol Diabetes Metab. 2025 May;8(3):e70055. doi: 10.1002/edm2.70055.
5
Xanthine Oxidoreductase: A Double-Edged Sword in Neurological Diseases.黄嘌呤氧化还原酶:神经疾病中的一把双刃剑
Antioxidants (Basel). 2025 Apr 17;14(4):483. doi: 10.3390/antiox14040483.
6
Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications.氧化应激与炎症在神经疾病发病机制中的作用:机制与影响
Acta Pharm Sin B. 2025 Jan;15(1):15-34. doi: 10.1016/j.apsb.2024.10.004. Epub 2024 Oct 16.
7
Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study.黄嘌呤氧化酶抑制剂非布司他对无症状高尿酸血症和肝功能不全患者心踝血管指数的影响:PRIZE研究的亚组分析
J Atheroscler Thromb. 2025 Apr 1;32(4):474-490. doi: 10.5551/jat.65087. Epub 2024 Oct 3.
8
The Effect of Tolvaptan on Metabolism and Electrolyte Homeostasis in Patients with Heart Failure: A Systematic Review and Meta-Analysis.托伐普坦对心力衰竭患者代谢及电解质稳态的影响:一项系统评价与Meta分析
Rev Cardiovasc Med. 2024 Sep 19;25(9):334. doi: 10.31083/j.rcm2509334. eCollection 2024 Sep.
9
Effects of hydrogen-rich water on blood uric acid in patients with hyperuricemia: A randomized placebo-controlled trial.富氢水对高尿酸血症患者血尿酸的影响:一项随机安慰剂对照试验。
Heliyon. 2024 Aug 15;10(16):e36401. doi: 10.1016/j.heliyon.2024.e36401. eCollection 2024 Aug 30.
10
Genetic variation in CCDC93 is associated with elevated central systolic blood pressure, impaired arterial relaxation, and mitochondrial dysfunction.CCDC93 基因变异与中心收缩压升高、动脉松弛受损和线粒体功能障碍有关。
PLoS Genet. 2024 Sep 9;20(9):e1011151. doi: 10.1371/journal.pgen.1011151. eCollection 2024 Sep.